These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 19574345)

  • 1. Lipid-induced mTOR activation in rat skeletal muscle reversed by exercise and 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside.
    Rivas DA; Yaspelkis BB; Hawley JA; Lessard SJ
    J Endocrinol; 2009 Sep; 202(3):441-51. PubMed ID: 19574345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMPK activation attenuates S6K1, 4E-BP1, and eEF2 signaling responses to high-frequency electrically stimulated skeletal muscle contractions.
    Thomson DM; Fick CA; Gordon SE
    J Appl Physiol (1985); 2008 Mar; 104(3):625-32. PubMed ID: 18187610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AICAR treatment for 14 days normalizes obesity-induced dysregulation of TORC1 signaling and translational capacity in fasted skeletal muscle.
    Drake JC; Alway SE; Hollander JM; Williamson DL
    Am J Physiol Regul Integr Comp Physiol; 2010 Dec; 299(6):R1546-54. PubMed ID: 20844264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of AICAR and exercise on insulin-stimulated glucose uptake, signaling, and GLUT-4 content in rat muscles.
    Jessen N; Pold R; Buhl ES; Jensen LS; Schmitz O; Lund S
    J Appl Physiol (1985); 2003 Apr; 94(4):1373-9. PubMed ID: 12496137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prior treatment with the AMPK activator AICAR induces subsequently enhanced glucose uptake in isolated skeletal muscles from 24-month-old rats.
    Oki K; Arias EB; Kanzaki M; Cartee GD
    Appl Physiol Nutr Metab; 2018 Aug; 43(8):795-805. PubMed ID: 29518344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin stimulation of glucose uptake fails to decrease palmitate oxidation in muscle if AMPK is activated.
    Winder WW; Holmes BF
    J Appl Physiol (1985); 2000 Dec; 89(6):2430-7. PubMed ID: 11090599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of AMP-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-D-ribonucleoside prevents leucine-stimulated protein synthesis in rat skeletal muscle.
    Pruznak AM; Kazi AA; Frost RA; Vary TC; Lang CH
    J Nutr; 2008 Oct; 138(10):1887-94. PubMed ID: 18806097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR.
    Sakamoto K; Göransson O; Hardie DG; Alessi DR
    Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E310-7. PubMed ID: 15068958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term AMP-regulated protein kinase activation enhances insulin-sensitive fatty acid uptake and increases the effects of insulin on fatty acid oxidation in L6 muscle cells.
    Kelly KR; Abbott MJ; Turcotte LP
    Exp Biol Med (Maywood); 2010 Apr; 235(4):514-21. PubMed ID: 20407084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term adenosine monophosphate-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside treatment increases the sirtuin 1 protein expression in skeletal muscle.
    Suwa M; Nakano H; Radak Z; Kumagai S
    Metabolism; 2011 Mar; 60(3):394-403. PubMed ID: 20362304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling.
    Bolster DR; Crozier SJ; Kimball SR; Jefferson LS
    J Biol Chem; 2002 Jul; 277(27):23977-80. PubMed ID: 11997383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside-induced AMP-activated protein kinase phosphorylation inhibits basal and insulin-stimulated glucose uptake, lipid synthesis, and fatty acid oxidation in isolated rat adipocytes.
    Gaidhu MP; Fediuc S; Ceddia RB
    J Biol Chem; 2006 Sep; 281(36):25956-64. PubMed ID: 16816404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of AMPK accompanies leucine- and glucose-induced increases in protein synthesis and insulin resistance in rat skeletal muscle.
    Saha AK; Xu XJ; Lawson E; Deoliveira R; Brandon AE; Kraegen EW; Ruderman NB
    Diabetes; 2010 Oct; 59(10):2426-34. PubMed ID: 20682696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of insulin-stimulated glycogen synthesis by 5-aminoimidasole-4-carboxamide-1-beta-d-ribofuranoside-induced adenosine 5'-monophosphate-activated protein kinase activation: interactions with Akt, glycogen synthase kinase 3-3alpha/beta, and glycogen synthase in isolated rat soleus muscle.
    Fediuc S; Gaidhu MP; Ceddia RB
    Endocrinology; 2006 Nov; 147(11):5170-7. PubMed ID: 16873531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMP-activated protein kinase enhances the expression of muscle-specific ubiquitin ligases despite its activation of IGF-1/Akt signaling in C2C12 myotubes.
    Tong JF; Yan X; Zhu MJ; Du M
    J Cell Biochem; 2009 Oct; 108(2):458-68. PubMed ID: 19639604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
    Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
    Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMP-activated Protein Kinase (AMPK) Control of mTORC1 Is p53- and TSC2-independent in Pemetrexed-treated Carcinoma Cells.
    Agarwal S; Bell CM; Rothbart SB; Moran RG
    J Biol Chem; 2015 Nov; 290(46):27473-86. PubMed ID: 26391395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of AMPK/mTOR/S6K1 signaling axis in mediating the physiological process of exercise-induced insulin sensitization in skeletal muscle of C57BL/6 mice.
    Liu X; Yuan H; Niu Y; Niu W; Fu L
    Biochim Biophys Acta; 2012 Nov; 1822(11):1716-26. PubMed ID: 22846606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of adenosine 5'-monophosphate-activated protein kinase subunits in skeletal muscle mammalian target of rapamycin signaling.
    Deshmukh AS; Treebak JT; Long YC; Viollet B; Wojtaszewski JF; Zierath JR
    Mol Endocrinol; 2008 May; 22(5):1105-12. PubMed ID: 18276828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats.
    Iglesias MA; Ye JM; Frangioudakis G; Saha AK; Tomas E; Ruderman NB; Cooney GJ; Kraegen EW
    Diabetes; 2002 Oct; 51(10):2886-94. PubMed ID: 12351423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.